晨霭微凉
Lv74
4070 积分
2022-05-11 加入
-
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
1小时前
已完结
-
Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial
2小时前
已完结
-
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
18天前
已完结
-
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
19天前
已完结
-
Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study
1个月前
已完结
-
Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study
1个月前
已完结
-
KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP
1个月前
已完结
-
Clinical characteristics and prognosis of liver injury induced by immune checkpoint inhibitors in patients with malignancies: A real‐world retrospective study
1个月前
已完结
-
Advances in Thyroid Pathology: High Grade Follicular cell-derived Thyroid Carcinoma and Anaplastic Thyroid Carcinoma
1个月前
已完结
-
Integrative single-cell transcriptome analysis reveals immune suppressive landscape in the anaplastic thyroid cancer
1个月前
已完结